Long-term persistence with evolocumab treatment and sustained reductions in LDL-cholesterol levels over 30 months: Final results from the European observational HEYMANS study
Autor: | Ray, Kausik K., Bruckert, Eric, Peronne-Filardi, Pasquale, Ebenbichler, Christoph, Vogt, Anja, Bridges, Ian, Sibartie, Mahendra, Dhalwani, Nafeesa |
---|---|
Zdroj: | In Atherosclerosis February 2023 366:14-21 |
Databáze: | ScienceDirect |
Externí odkaz: |